Bli medlem
Bli medlem

Du är här


Aino Health AB (publ): Aino Health's planned listing on Nasdaq First North


November 27, 2016


Aino Health's planned listing on Nasdaq First North

The Board of Directors in Aino Health AB (publ) ("Aino Health" or the
"Company") has decided to apply for listing of the Company's shares on Nasdaq
First North, and in connection with the listing the Board of Directors has
decided on a share issue of up to 2,070,000 newly issued shares directed to
the general public and institutional investors (the "Offer"), whereby the
Company will receive a maximum of SEK 48.8 M after transaction costs. A
prospectus relating to the Offer will be published on November 27, 2016.
Preliminary first day of trading is on December 16, 2016.

The total value of the Offer, if fully subscribed, amounts to SEK 53.8 M
distributed on 1,800,000 newly issued shares (the "Share Issue") and an
over-allotment of up to 270,000 existing shares at a share price of 26.00 SEK
(the "Over-allotment"). The Over-allotment can be exercised in the event of a
major interest in the Offer. The Over-allotment is implemented as a part of
stabilization, after which the Company may issue an additional 270,000 shares
through the Over-allotment option directed to Erik Penser Bank.

A number of investors have agreed to share subscription agreements of SEK 31.9
M, corresponding to approximately 68 percent of the Offer excluding the

Aino Health's business concept is to increase health awareness in various
organizations and to reduce personnel sickness absence by promoting an
IT-based process solution to both private and public companies and
organizations. The Company provides services and tools for the entire value
chain of health- and safety management as well as related services, processes
and methods.

The social need to improve the population health eg by reducing sickness
absence levels places new demands on employers and creates the need for new
solutions. Being innovative and offering modern solutions, Aino Health
enables a revolutionary and effective health management for companies and
organizations. This means that Aino Health's potential client base is very

The Offer

* The Offer constitutes of up to 1,800,000 newly issued shares and an
Over-allotment of up to 270,000 existing shares in the event of major
interest in the Offer
* The share price is 26.00 SEK per share, corresponding to a pre-money equity
valuation of approximately SEK 94.2 M (EUR 9.6 M)
* Erik Penser Bank will, during a period of 30 days from the first day of
trading on Nasdaq First North, engage in transactions that stabilize,
maintain or otherwise affect the price of the shares.
* The Company has, within the frame of the stabilization, agreed on an
Over-allotment option to Erik Penser Bank to issue additional 270,000
* The number of shares in the Company will increase with up to 2,070,000
shares, corresponding to 36 percent of the total number of shares in the
Company after the completion of the Offer
* The Offer amounts to SEK 46.8 M and SEK 53.8 M if the Over-allotment is
fully exercised. The Company will receive up to SEK 48.8 M after
transaction costs of SEK 5.0 M
* Aino Health has applied for listing of the Company's shares on Nasdaq First
North and preliminary first day of trading on December 16, 2016
* A prospectus with full terms has been published today on November 27, 2016
and is available on Aino Health's website,

Indicative time schedule

Subscription period: November 28 - December
8, 2016
Publication of the result: December 9, 2016
Preliminary first day of trading: December 16, 2016

Background and reasons

Aino Health Management Oy was founded in Finland in 1994 and has been
operating its current business model since 2010. The company has developed a
complete system of IT-based services with a focus to improve corporate health
and reduce sickness absence levels in private and public organizations.

The general corporate health level is most often expressed in terms of
sickness absences and measured in terms of sick pay costs and salaries to
substitutes. Furthermore, there are additional costs that are hard to measure
such as reduced quality of delivered products and services as a consequence
of a changing and unstable workforce, as a result of the general state at the
work place, in full and in working groups.

A complete service provided by Aino Health includes:

* Integration of the customer's personnel records and Aino Health's central
IT-based database, Health Manager
* HealthManager collects and analyses personnel data including suggestions
for actions when the sickness absence reach a certain level as well as
monitoring of supervisors and managers' actions and signal of possible
passivity regarding personnel sickness absences
* Sickness absence reporting and personal follow-up by qualified medical
personnel through the Aino Health Call center/Health Desk
* SafetyManager, to be launched in 2017, will serve as the customer's
integrated solution for health and safety management in different
organizations including registration, monitoring and reporting to top level
management of events and processes related to the company safety and
working environment

Aino Health's systems can be described as tools and services to be able to
establish and maintain low sickness absence levels and reduce costs through
ensuring that the employees get the attention needed when they are absent.
Underlying reasons and patterns of the sickness absence are being monitored
in consultation with employees and unions, and any passivity from managers
can quickly be detected. Sickness absence can be a complex problem and can be
explained by both obvious and hidden causes.

The subsidiary, Aino Health Management Oy, has established a reputable client
base consisting of both private and public organizations in Finland. The
customer base consists of approximately 150 customers, and around 30
customers with approximately 33 000 employees combined are using the
HealthManager service. In 2015, 20 percent of Aino Health's customers
accounted for about 85 percent of the turnover.

Aino Health is facing an expansion with the aim of further establishment in
Europe. The first step will be a market launch in Sweden and Germany where
discussions and negotiations with a number of potential customers have been

The current corporate structure consists of the parent company Aino Health AB
(publ), the Swedish subsidiary Aino Health Sweden AB and the fully owned
Finnish subsidiary Aino Health Management Oy with its subsidiary Aino Active
Oy. The corporate group will be expanded and a new subsidiary will be
established in each new country Aino Health enters.

Aino Health's objective is to achieve a strong growth, partly by growing
organically in already established markets and partly through entering new
geographical markets. The objective is that establishments on new markets
should be self-financing without the need for additional capital after two

The Board of Directors in Aino Health has, to provide the Company with
sufficient working capital and strengthen the financial position, on November
21, 2016 decided on the Offer based on EGM's approval on September 19, 2016.
The Offer amounts to a total of SEK 53.8 M if fully subscribed and including
the Over-allotment option, after which the Company will receive up to SEK
48.8 M after transaction costs of SEK 5.0 M. The proceeds will be utilized
for working capital with the exception of 1-2 million relating to adjustments
of software.

The offer and the subsequent listing on Nasdaq First North will create
liquidity in the Aino Health share. The listing of Aino Health will grant the
company access to the stock market, which facilitates future fund raising.
The listing also enables Aino Health to, over time, get new shareholders that
could strengthen the company development. The listing is also expected to
have positive effects on the company's relationships with business partners,
employees and potential clients. The Board of Directors of Aino Health assess
that the company is well suited for a broadening of ownership and listing of

Investor meetings

Aktiespararna Aino Health will be presented at Aktiespararnas
aktiedagar in Stockholm Monday, November 28. Additional information

Stockholm Presentation, Monday December 5 at 17:30, Erik Penser
Bank, Apelbergsgatan 27. Sign up on

Stockholm Lunch presentation Tuesday December 6 at 12:00, Erik
Penser Bank, Apelbergsgatan 27. Sign up on

Prospectus and application forms

The prospectus with the terms and instructions and application forms are
available on the Company's website ( and at Erik Penser
Bank's website ( The prospectus can be ordered, free of
charge, by e-mail; An application can also be made via

Erik Penser AB is the financial advisor and Advokatfirman Lindahl KB is the
legal adviser in the Offer. Erik Penser AB is Certified Adviser.

This information is information that Aino Health AB (publ) is obliged to make
public pursuant to the EU Market Abuse Regulation. The information was
submitted for publication, through the agency of the contact person set out
above, at November 27 CET on 18:00 2016.

For more information, please contact:

Jyrki Eklund, CEO
Phone: +358 40 042 4221

About Aino Health

Aino Health operates within Corporate Health Management. The company has
developed a complete system of IT-based services with a focus to improve
corporate health and reduce sickness absence levels in private and public

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aino Health AB (publ) via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.